Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement

Stock Information for Syros Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Syros Pharmaceuticals Inc.

Syros and Tyme Technologies Announce Stockholder Approval of Merger
TYME Technologies, Inc. Announces Proxy Advisory Firms Glass Lewis and ISS Recommend Stockholders Vote "FOR" Proposed Merger of Syros and Tyme
TYME TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME
TYME TECHNOLOGIES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Resolute Forest Products Inc. (NYSE - RFP), Meridian Bioscience, Inc. (Nasdaq - VIVO), TYME Technologies (Nasdaq - TYME)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Tyme Technologies, Inc. Merger
SHAREHOLDER ALERT: Weiss Law Investigates Syros Pharmaceuticals, Inc.
Investor Alert - The M&A Class Action Firm Announces an Investigation of Tyme Technologies, Inc. - TYME

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.